These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
52 related articles for article (PubMed ID: 25502748)
1. Do recent US Supreme Court rulings on patenting of genes and genetic diagnostics affect the practice of genetic screening and diagnosis in prenatal and reproductive care? Chandrasekharan S; McGuire AL; Van den Veyver IB Prenat Diagn; 2014 Oct; 34(10):921-6. PubMed ID: 24989832 [TBL] [Abstract][Full Text] [Related]
5. Myriad and its implications for patent protection of isolated natural products in the United States. Wong AY; Chan AW Chin Med; 2014; 9():17. PubMed ID: 25006347 [TBL] [Abstract][Full Text] [Related]
6. Sorry you asked? Cook-Deegan R; Geary J; Hapke K; Skvarkova Z; Filipek M; Leaver J J Law Biosci; 2024; 11(1):lsae010. PubMed ID: 38841266 [TBL] [Abstract][Full Text] [Related]
7. The "real world" barriers and solutions to Candida vaccine patent prosecutions: an analysis of U.S. Patent and Trademark Office actions on related applications. Wang SJ Hum Vaccin Immunother; 2012 Oct; 8(10):1443-9. PubMed ID: 22894949 [TBL] [Abstract][Full Text] [Related]
8. Framing Ethical Concerns and Attitudes towards Human Gene Patents in the Chinese Press. Du L; Lin S; Kamenova K Asian Bioeth Rev; 2020 Sep; 12(3):307-323. PubMed ID: 33717340 [TBL] [Abstract][Full Text] [Related]
9. Curfman G; Boumil MM J Law Med Ethics; 2023; 51(3):689-693. PubMed ID: 38088594 [TBL] [Abstract][Full Text] [Related]
10. Patentability of human genes: the conceptual differences between the industrialised and Latin American countries. Bergel SD J Community Genet; 2015 Jul; 6(3):321-7. PubMed ID: 25929592 [TBL] [Abstract][Full Text] [Related]
11. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. Jaiswal N; Haynesworth SE; Caplan AI; Bruder SP J Cell Biochem; 1997 Feb; 64(2):295-312. PubMed ID: 9027589 [TBL] [Abstract][Full Text] [Related]
12. Natural Products as a Foundation for Drug Discovery. Beutler JA Curr Protoc Pharmacol; 2019 Sep; 86(1):e67. PubMed ID: 31539923 [TBL] [Abstract][Full Text] [Related]
13. Myriad's impact on gene patents. Aboy M; Liddell K; Liddicoat J; Crespo C Nat Biotechnol; 2016 Nov; 34(11):1119-1123. PubMed ID: 27824831 [No Abstract] [Full Text] [Related]
14. The impact of Myriad and Mayo: will advancements in the biological sciences be spurred or disincentivized? (Or was biotech patenting not complicated enough?). Gordon J Cold Spring Harb Perspect Med; 2014 Dec; 5(5):a020917. PubMed ID: 25502748 [TBL] [Abstract][Full Text] [Related]
15. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected? Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460 [TBL] [Abstract][Full Text] [Related]
16. Baseball bats and chocolate chip cookies: the judicial treatment of DNA in the myriad genetics litigation. Binnie I; Park-Thompson V Cold Spring Harb Perspect Med; 2014 Dec; 5(6):. PubMed ID: 25524722 [TBL] [Abstract][Full Text] [Related]
17. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing. Bergin C Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200 [TBL] [Abstract][Full Text] [Related]
18. Gene patents, patenting life and the impact of court rulings on US stem cell patents and research. Matthews KR; Cuchiara ML Regen Med; 2014 Mar; 9(2):191-200. PubMed ID: 24750060 [TBL] [Abstract][Full Text] [Related]
19. Patent first, ask questions later: morality and biotechnology in patent law. Bagley MA William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677 [TBL] [Abstract][Full Text] [Related]